Histidine-enriched multifunctional peptide vectors with enhanced cellular uptake and endosomal escape for gene delivery
Source abstract
Abstract
Peptide vectors offer a promising gene delivery approach because of their biocompatibility and ease of functionalization. This article describes the design and evaluation of a series of multifunctional peptides and their gene delivery abilities. The peptides were composed of a cell-penetrating segment, stearyl moiety, cationic amphiphilic α-helical segment, and cysteine and histidine residues. The proton sponge effect of histidine residues at low pH and the α-helical conformation should improve endosomal escape. Inclusion of d-type amino acids should improve proteolytic stability. The conformation, particle size and zeta potential of peptide/DNA complexes were characterized by circular dichroism and dynamic light scattering. Gene transfection efficiency was investigated by fluorescence-activated cell sorting and confocal microscopy. Transfection efficiencies of the designed peptide vectors were better than those of C18-C(LLKK)3C-TAT and Lipo2000. d-Type peptide C18-c(llhh)3c-tat showed three times higher transfection efficiency at N/P ratios of 6 and 8 than Lipo2000 in NIH-3T3 and 293T cells. All peptides showed lower cytotoxicity than Lipo2000 in NIH-3T3 and 293T cells. In the presence of trypsin or serum in vitro, d-type peptides showed better stability than l-type peptides. Overall, the designed histidine-enriched multifunctional peptide gene vectors promoted cellular uptake, endosomal escape and gene transfection.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Virus-based gene therapy research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Toxicology and Medical Countermeasures
Beijing Institute of Pharmacology and Toxicology
Beijing
P. R. China
Clinical Laboratory
Funding
National Natural Science Foundation of China
References (49)
Show source-provided references
1. Naldini · Nature · 2015 · 526 · 35110.1038/nature15818 ↗
2. Kane · Neuro Oncol. · 2015 · 17 · 2410.1093/neuonc/nou355 ↗
3. Kaufmann · EMBO Mol. Med. · 2013 · 5 · 164210.1002/emmm.201202287 ↗
4. Verma · Nature · 1997 · 389 · 23910.1038/38410 ↗
5. Mintzer · Chem. Rev. · 2009 · 109 · 25910.1021/cr800409e ↗
6. Oliveira · Expert Opin. Drug Delivery · 2015 · 12 · 2710.1517/17425247.2014.945421 ↗
7. Nakamura · J. Controlled Release · 2007 · 119 · 36010.1016/j.jconrel.2007.03.010 ↗
8. Zuhorn · Eur. Biophys. J. · 2007 · 36 · 34910.1007/s00249-006-0092-4 ↗
9. Copolovici · ACS Nano · 2014 · 8 · 197210.1021/nn4057269 ↗
10. Cho · Small · 2013 · 9 · 196410.1002/smll.201201973 ↗
11. Ferrer-Miralles · Trends Biotechnol. · 2008 · 26 · 26710.1016/j.tibtech.2008.02.003 ↗
12. Salomone · J. Controlled Release · 2012 · 163 · 29310.1016/j.jconrel.2012.09.019 ↗
13. Nakase · Acc. Chem. Res. · 2012 · 45 · 113210.1021/ar200256e ↗
14. Patil · J. Am. Chem. Soc. · 2012 · 134 · 719610.1021/ja210026m ↗
15. Li · J. Am. Chem. Soc. · 2012 · 134 · 1215710.1021/ja3036256 ↗
16. Ruoslahti · Adv. Mater. · 2012 · 24 · 374710.1002/adma.201200454 ↗
17. Vivès · J. Biol. Chem. · 1997 · 272 · 1601010.1074/jbc.272.25.16010 ↗
18. Shiraishi · Nat. Protoc. · 2006 · 1 · 63310.1038/nprot.2006.92 ↗
19. Hoyer · Acc. Chem. Res. · 2011 · 45 · 104810.1021/ar2002304 ↗
20. Snyder · Pharm. Res. · 2004 · 21 · 38910.1023/B:PHAM.0000019289.61978.f5 ↗
21. Renigunta · Bioconjugate Chem. · 2006 · 17 · 32710.1021/bc050263o ↗
22. Torchilin · Adv. Drug Delivery Rev. · 2008 · 60 · 54810.1016/j.addr.2007.10.008 ↗
23. Kim · J. Controlled Release · 2011 · 152 · 11010.1016/j.jconrel.2011.02.013 ↗
24. Li · Adv. Mater. · 2009 · 21 · 449210.1002/adma.200900934 ↗
25. Hwang · Biomacromolecules · 2014 · 15 · 357710.1021/bm500843r ↗
26. Convertine · Biomacromolecules · 2010 · 11 · 290410.1021/bm100652w ↗
27. Gu · Biomacromolecules · 2013 · 14 · 338610.1021/bm401139e ↗
28. Varkouhi · J. Controlled Release · 2011 · 151 · 22010.1016/j.jconrel.2010.11.004 ↗
29. Pack · Biotechnol. Bioeng. · 1999 · 67 · 21710.1002/(SICI)1097-0290(20000120)67:2<217::AID-BIT11>3.0.CO;2-Q ↗
30. Moreira · Acta Biomater. · 2009 · 5 · 299510.1016/j.actbio.2009.04.021 ↗
31. Singh · Chem. Biol. · 2004 · 11 · 71310.1016/j.chembiol.2004.03.026 ↗
32. Ferrer-Miralles · Trends Biotechnol. · 2008 · 26 · 26710.1016/j.tibtech.2008.02.003 ↗
33. Yu · J. Am. Chem. Soc. · 1998 · 120 · 997910.1021/ja981654z ↗
34. Hu · Biomacromolecules · 2011 · 12 · 383910.1021/bm201098j ↗
35. Li · J. Am. Chem. Soc. · 2013 · 135 · 990710.1021/ja404215g ↗
36. Rajpal · J. Controlled Release · 2012 · 157 · 26010.1016/j.jconrel.2011.09.081 ↗
37. Yang · Adv. Healthcare Mater. · 2013 · 2 · 48110.1002/adhm.201200154 ↗
38. Lo · Biomaterials · 2008 · 29 · 240810.1016/j.biomaterials.2008.01.031 ↗
39. Luan · J. Mater. Chem. B · 2015 · 3 · 106810.1039/C4TB01353K ↗
40. Crombez · Curr. Pharm. Des. · 2008 · 14 · 365610.2174/138161208786898842 ↗
41. Fittipaldi · J. Biol. Chem. · 2003 · 278 · 3414110.1074/jbc.M303045200 ↗
42. Richard · J. Biol. Chem. · 2003 · 278 · 58510.1074/jbc.M209548200 ↗
43. Ghosh · J. Med. Chem. · 2014 · 57 · 142810.1021/jm401680a ↗
44. Meng · Langmuir · 2012 · 28 · 501710.1021/la3003355 ↗
45. Wiradharma · Biomaterials · 2011 · 32 · 220410.1016/j.biomaterials.2010.11.054 ↗
46. Wang · Anal. Chem. · 2014 · 86 · 1008410.1021/ac501343b ↗
47. Yang · ACS Appl. Mater. Interfaces · 2015 · 7 · 273510.1021/am507800e ↗
48. Kaplan · J. Controlled Release · 2005 · 102 · 24710.1016/j.jconrel.2004.10.018 ↗
49. Wiradharma · Biomaterials · 2011 · 32 · 910010.1016/j.biomaterials.2011.08.020 ↗